Fulgent Genetics, Inc.
FLGT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $118 | $88 | $67 | $55 |
| Short-Term Investments | $258 | $205 | $253 | $203 |
| Receivables | $79 | $85 | $80 | $77 |
| Inventory | $10 | $9 | $9 | $8 |
| Other Curr. Assets | $43 | $42 | $7 | $10 |
| Total Curr. Assets | $507 | $429 | $417 | $354 |
| Property Plant & Equip (Net) | $112 | $110 | $107 | $106 |
| Goodwill | $25 | $22 | $22 | $22 |
| Intangibles | $135 | $131 | $133 | $135 |
| Long-Term Investments | $412 | $484 | $494 | $570 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $23 | $23 | $33 | $33 |
| Total NC Assets | $707 | $771 | $789 | $866 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,215 | $1,200 | $1,206 | $1,220 |
| Liabilities | – | – | – | – |
| Payables | $18 | $19 | $18 | $18 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $31 | $30 | $31 | $30 |
| Other Curr. Liab. | $22 | $21 | $15 | $23 |
| Total Curr. Liab. | $72 | $71 | $66 | $73 |
| LT Debt | $6 | $6 | $6 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $7 | $6 | $6 | $6 |
| Other NC Liab. | $9 | $5 | $5 | $5 |
| Total NC Liab. | $21 | $17 | $17 | $18 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $5 | $6 |
| Total Liabilities | $94 | $88 | $83 | $91 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $553 | $560 | $579 | $590 |
| AOCI | $7 | $6 | $4 | -$0 |
| Other Equity | $566 | $551 | $544 | $543 |
| Total Equity | $1,126 | $1,117 | $1,127 | $1,133 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$5 | -$5 | -$4 | -$4 |
| Total Liab. & Tot. Equity | $1,215 | $1,200 | $1,206 | $1,220 |
| Net Debt | -$110 | -$80 | -$60 | -$47 |